Literature DB >> 12832337

Non-HDL cholesterol versus apolipoprotein B in diabetic dyslipoproteinemia: alternatives and surrogates versus the real thing.

Allan D Sniderman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12832337     DOI： 10.2337/diacare.26.7.2207

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  7 in total

1.  Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.

Authors:  G Bruno; F Merletti; A Biggeri; G Bargero; S Prina-Cerai; G Pagano; P Cavallo-Perin
Journal:  Diabetologia       Date:  2006-03-09       Impact factor: 10.122

2.  Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes.

Authors:  Assim A Alfadda; Afshan Masood; Shaffi Ahamed Shaik; Hafedh Dekhil; Michael Goran
Journal:  Int J Endocrinol       Date:  2013-04-09       Impact factor: 3.257

3.  Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.

Authors:  Michel P Hermans; Frank M Sacks; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2011-02-28       Impact factor: 9.951

4.  Argan Oil Exerts an Antiatherogenic Effect by Improving Lipids and Susceptibility of LDL to Oxidation in Type 2 Diabetes Patients.

Authors:  M M Ould Mohamedou; K Zouirech; M El Messal; M S El Kebbaj; A Chraibi; A Adlouni
Journal:  Int J Endocrinol       Date:  2011-11-01       Impact factor: 3.257

5.  Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.

Authors:  Shuang Zheng; Tingting Han; Hua Xu; Huan Zhou; Xingxing Ren; Peihong Wu; Jun Zheng; Lihua Wang; Ming Zhang; Yihong Jiang; Yawen Chen; Huiying Qiu; Wei Liu; Yaomin Hu
Journal:  BMJ Open       Date:  2017-01-20       Impact factor: 2.692

6.  Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.

Authors:  Liliana Fonseca; Sílvia Paredes; Helena Ramos; José Carlos Oliveira; Isabel Palma
Journal:  Lipids Health Dis       Date:  2020-06-06       Impact factor: 3.876

7.  Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM.

Authors:  Michel P Hermans; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2013-02-27       Impact factor: 9.951
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.